PCSK9 inhibitor
Hypercholesterolemia (statin‑resistant)
PreclinicalActive
Key Facts
About Nyrada
Australian‑listed biotech advancing TRPC‑channel inhibitors for cardiovascular and neurological unmet needs.
View full company profileHypercholesterolemia (statin‑resistant)
Australian‑listed biotech advancing TRPC‑channel inhibitors for cardiovascular and neurological unmet needs.
View full company profile